Avanos Medical Inc (AVNS)
Payables turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 681,100 | 745,400 | 727,800 | 745,300 | 714,500 |
Payables | US$ in thousands | 56,300 | 67,900 | 56,400 | 67,600 | 83,000 |
Payables turnover | 12.10 | 10.98 | 12.90 | 11.03 | 8.61 |
December 31, 2023 calculation
Payables turnover = Cost of revenue ÷ Payables
= $681,100K ÷ $56,300K
= 12.10
The payables turnover ratio for Avanos Medical Inc has fluctuated over the past five years, ranging from 3.56 to 6.74. This ratio measures how efficiently the company is managing its accounts payable by evaluating the number of times a company pays off its suppliers during a specific period.
In 2023, the payables turnover ratio was 5.21, indicating that Avanos Medical Inc paid its suppliers approximately 5.21 times during the year. This suggests a moderate level of efficiency in managing its accounts payable compared to previous years.
The decreasing trend from 2021 to 2022 followed by a slight increase in 2023 may indicate that the company is taking longer to pay off its suppliers compared to the previous year but is still managing its payables effectively. However, further analysis is needed to understand the reasons behind these fluctuations and whether they are in line with industry norms or company-specific strategies.
Overall, the payables turnover ratio provides insight into Avanos Medical Inc's ability to efficiently manage its payment obligations to suppliers, and monitoring changes in this ratio over time can help assess the company's financial health and operational efficiency in managing its working capital.
Peer comparison
Dec 31, 2023